clofibrate has been researched along with Ischemia in 6 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with clofibrate is also associated with a decrease in ANP and ANPr expression." | 5.91 | PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. ( Cano-Martínez, A; Castrejón-Téllez, V; Díaz-Díaz, E; Ibarra-Lara, L; Osorio-Yáñez, C; Pavón, N; Rubio-Ruíz, ME; Sánchez-Aguilar, M; Soria-Castro, E, 2023) |
| " To examine the role of stimulated FAO during ischemia, Etomoxir (Eto), clofibrate, and WY-14,643 compounds were given 5 days prior to the induction of ischemia/reperfusion (I/R) injury." | 3.70 | Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. ( Crew, MD; Dai, G; Gonzalez, FJ; Peters, JM; Portilla, D; Proia, AD, 2000) |
| "Treatment with clofibrate is also associated with a decrease in ANP and ANPr expression." | 1.91 | PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. ( Cano-Martínez, A; Castrejón-Téllez, V; Díaz-Díaz, E; Ibarra-Lara, L; Osorio-Yáñez, C; Pavón, N; Rubio-Ruíz, ME; Sánchez-Aguilar, M; Soria-Castro, E, 2023) |
| "Type V hyperlipemia is not very common." | 1.26 | [Type V hyperlipemia. 54 cases (author's transl)]. ( Beaumont, V; Buxtorf, JC; Jacotot, B; Schlesinger, M, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Aguilar, M | 1 |
| Ibarra-Lara, L | 1 |
| Cano-Martínez, A | 1 |
| Soria-Castro, E | 1 |
| Castrejón-Téllez, V | 1 |
| Pavón, N | 1 |
| Osorio-Yáñez, C | 1 |
| Díaz-Díaz, E | 1 |
| Rubio-Ruíz, ME | 1 |
| Portilla, D | 1 |
| Dai, G | 1 |
| Peters, JM | 1 |
| Gonzalez, FJ | 1 |
| Crew, MD | 1 |
| Proia, AD | 1 |
| Schlesinger, M | 1 |
| Jacotot, B | 1 |
| Beaumont, V | 1 |
| Buxtorf, JC | 1 |
| Dormandy, J | 1 |
| Postlethwaite, J | 1 |
| Goyle, K | 1 |
| Weiss, HJ | 1 |
| Haviar, V | 1 |
| Riecanský, L | 1 |
| Kusá, O | 1 |
| Luknárová, O | 1 |
1 review available for clofibrate and Ischemia
| Article | Year |
|---|---|
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi | 1976 |
5 other studies available for clofibrate and Ischemia
| Article | Year |
|---|---|
PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response.
Topics: Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Clofibrate; Inflammation; Ischemia; Metabo | 2023 |
Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Carnitine O-Palmitoyltransferase; Clofibrate; Cre | 2000 |
[Type V hyperlipemia. 54 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Electrophoresis; Child; Child, Preschool; Cholest | 1979 |
Haemorheological therapy.
Topics: Animals; Blood Viscosity; Clofibrate; Fibrin; Fibrinogen; Humans; Intermittent Claudication; Ischemi | 1977 |
Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
Topics: Adult; Aged; Cholesterol; Clofibrate; Coronary Disease; Fatty Acids; Female; Glycerol; Heparin; Huma | 1972 |